Recognition for her sentinel contributions to the assessment of clinical competence and management of prescription drugs
PICH2GO is an exciting series of educational and networking events co-hosted this year by PICH and Shriners Hospitals for Children® – Canada.
Innate Immune Response in Diseased Brain: Lost in Translation
Invited Speaker: JASNA KRIZ, MD, PHD
Clinical studies are the foundation of evidence-based medicine and are critical for developing management strategies to improve outcomes for patients.
Come and join this forum to update your knowledge about women-specific issues in heart disease.
The RI-MUHC Trainee Committee and CTB Technology Platforms invite you to attend the Platform Expo on October 3, 2019.
MeDiC team raised funds for a new competition to benefit trainees as part of the MUHC Foundation’s Run for a Reason initiative
Join us today and make a difference! Careers
Researchers uncover new protein that plays key role in bacterial infections
Congratulations to Erwin Schurr for his new grant from the Canada Foundation for Innovation’s (CFI) John R. Evans Leaders Fund.
Scientists propose diagnostic tools to identify, and possibly limit, the effects of sarcopenia, a disease that significantly reduces the quality of life of the aging population
New Trends in Small Molecule Drug Discovery: Artificial Intelligence, Cancer-Cell Vulnerabilities and Immunology.
RI-MUHC student Hunter S. Shaw’s publication makes the cover, with a work of art from the Convergence Initiative
The Cancer Research Program at the RI-MUHC is pleased to invite you to join us for our 2nd annual exclusive vendor showcase
Effective September 1, 2019, he will assume the mandate previously held by Dr. Constantin Polychronakos.
Learn about our research from the lab to new treatments. Food, drinks and family-friendly activities.
Ranked first of 626 in the CIHR postdoctoral competition, in 2020 Claire Gizowski will be forging ahead with a prestigious international fellowship instead
Five-day event drew 50 graduate student research trainees and 30 faculty members from across Canada and the United Kingdom
LeishDerm:an HSP90 inhibitor-based formulation cures experimental cutaneous leishmaniasis by parasite killing and modulating host immune response
Speaker: Patrícia Sampaio Tavares Veras, MD, PhD
Immunotherapy for Early Stage Lung Cancer – Progress and Potential
Speaker: Dr. Patrick Forde
The Extracellular Vesicle Network is multi-disciplinary collaborative research group with a common addiction: understanding and exploiting the use of Extracellular Vesicles.
Rates of colonization of two health-associated infections tumbled soon after historic hospital move
Congratulations to students who contributed to the scientific life of our institute this summer!